About PSM
PSM Advisory Board approves policy resolution on reimbursement practices and supply chain safety
PSM opposes the practice of reimbursing pharmacies below the cost of acquisition of medicine and supports efforts to reform reimbursement systems that eliminate this market dynamic that threatens the safety of our drug supply.
[...]PSM applauds NNOAC statement of concern about Canadian drug importation
“We are deeply concerned about the impact importation of unapproved foreign prescription drugs will have on counterfeit medication in the United States, especially as FDA considers approving additional SIPs.”
[...]Explainer: eBay and the Department of Justice settle over pill press sales
An explainer for the $59mm settlement between eBay and the Department of Justice over pill press sales. What does this mean for the problem of illegal pill presses? How is eBay responsible for what a buyer and a seller do on its platform?
[...]Are Canadian patients struggling with drug shortages already?
PSM’s Shabbir Imber Safdar speaks to Canadian patient advocate Durhane Wong-Rieger about the drug shortage situation in Canada.
[...]What medicines do U.S. states want to import from Canada’s drug supply?
What drugs have states said they plan to export from Canada’s drug supply? We combed all their applications to the FDA and compiled that list into one document.
[...]The Partnership for Safe Medicines supports S. 2943, the SHOP SAFE Act
On January 17, 2024 PSM wrote the Senate Subcommittee on Intellectual Property to endorse S.2934, which would expand the Trademark Act of 1946 to extend liability for selling harmful counterfeits to online platforms. Read the letter here.
[...]Partnership for Safe Medicines Condemns the Weakening of the U.S. Drug Supply through Canadian Drug Importation + Full coverage of decision
PSM’s statement on the FDA decision and full coverage including media stories, official documents, and statements from stakeholders.
[...]PSM Executive Director to Speak at USPTO Roundtable on Counterfeits
Shabbir Imber Safdar, executive director of the Partnership for Safe Medicines, will participate in the upcoming United States Patent and Trademark Office Roundtable: Future strategies in anti-counterfeiting and anti-piracy.
[...]PSM and ADAP Advocacy call for more awareness about counterfeit medicines
Data recently shared in the Morbidity and Mortality Weekly Report highlights a growing problem: Counterfeit pill availability is rising in the drug supply chain, but also the illicit drug market.
[...]Teach Your Community With These Conference Slides
Running slides between conference sessions and during breaks is a great way to fit in a little extra information. Use these slides to teach your community about counterfeit medicines in the U.S.
[...]